KUALA LUMPUR, Dec 21 (Bernama) – Henry Schein, Inc. and Vets First Choice announced a new standalone public company named Covetrus resulting from the planned spin-off of the Henry Schein Animal Health business and the subsequent merger with Vets First Choice.
According to a statement, Covetrus reflects the company’s deep partnership with the veterinary community and its efforts to ‘Advance the World of Veterinary Medicine’.
The new company will be a global, technology-enabled animal health business supporting the companion, equine and large-animal veterinary markets.
Covetrus will also combine leading practice management software, prescription management, multi-channel client engagement services and supply chain infrastructure to promote connectivity between veterinarians and their clients.
Covetrus will employ more than 5,000 team members across approximately 25 countries with approximately 100,000 customers across major geographic regions, including North America, Europe, Australasia and South America.
The transaction is expected to be completed in the first quarter of 2019. Henry Schein Animal Health and Vets First Choice will continue to operate as two independent, separate organisations prior to the closing of the transaction.
Henry Schein, Inc. is a solutions company for health care professionals powered by a network of people and technology. Vets First Choice is an innovator in technology-enabled services that empower veterinarians. More details at www.henryschein.com and www.vetsfirstchoice.com
-- BERNAMA
No comments:
Post a Comment